ArticleMediterranean journal of hematology and infectious diseases2026
First-Line Flumatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A 3-Month Landmark-Evaluable Real-World Experience.
Dangui Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.